Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

PURPOSE: Immune checkpoint inhibitors (ICI) have shown marked responses in patients with non-small cell lung cancer (NSCLC) in clinical trials. However, because such trials comprise cohorts selected based on specific criteria, it is unclear if their results represent routine clinical practice. METHO...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Cancer Res Clin Oncol
मुख्य लेखकों: Ahn, Beung-Chul, Pyo, Kyoung-Ho, Xin, Chun-Feng, Jung, Dongmin, Shim, Hyo Sup, Lee, Chang Young, Park, Seong Yong, Yoon, Hong In, Hong, Min Hee, Cho, Byoung Chul, Kim, Hye Ryun
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer Berlin Heidelberg 2019
विषय:
Original Article – Clinical Oncology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527531/
https://ncbi.nlm.nih.gov/pubmed/30911841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-019-02899-y
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन